Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
2196Pharmaceuticals
HK$16.12−2.60%As of Oct 29vs prior close
- Market cap
- $1.1B
- P/E (TTM)
- 2.1×
- P/E (FY1)
- 9.4×
- From 52W high
- −30.48%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥42.6B
- Net margin
- 8.23%
- Dividend yield
- 2.79%
Nomior Score
38
Steady ProfileBottom 26% of the scored universe
Growth45
Quality45
Value65
Momentum18
Resilience48
Growth
−1.77%revenue a year over 3 fiscal years
YE22 CN¥44BLTM CN¥42.6B
Connections
Revenue to profitYE25
8% of revenue became net profit, up 1 pt on a year.